Folate in colorectal cancer, prostate cancer and cardiovascular disease

References

• Charles D. H., Ness A. R., Campbell D., Smith G. D., Whitley E., Hall M. H. Folic acid supplements in pregnancy and birth outcome: re‐analysis of a large randomised controlled trial and update of Cochrane review. Paediatr Perinat Epidemiol 2005; 19: 112–24
   PubMed Web of Science ®Google Scholar
• Bailey L. B., Berry R. J. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 2005; 81: 1213S–17S
   PubMed Web of Science ®Google Scholar
• Zetterberg H. Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol 2004; 2: 7
   PubMedGoogle Scholar
• Zetterberg H., Regland B., Palmer M., Ricksten A., Palmqvist L., Rymo L., et al. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet 2002; 10: 113–18
   PubMed Web of Science ®Google Scholar
• Lewis S. J., Lawlor D. A., Davey Smith G., Araya R., Timpson N., Day I. N., et al. The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta‐analysis. Mol Psychiatry 2006; 11: 352–60
   PubMed Web of Science ®Google Scholar
• Taylor M. J., Carney S., Geddes J., Goodwin G. Folate for depressive disorders. Cochrane Database Syst Rev 2003; CD003390
   Google Scholar
• Lewis S. J., Zammit S., Gunnell D., Smith G. D. A meta‐analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am J Med Genet B Neuropsychiatr Genet 2005; 135: 2–4
   Web of Science ®Google Scholar
• Gjesdal C. G., Vollset S. E., Ueland P. M., Refsum H., Drevon C. A., Gjessing H. K., et al. Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 2006; 166: 88–94
   PubMed Web of Science ®Google Scholar
• Sato Y., Honda Y., Iwamoto J., Kanoko T., Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. J Am Med Assoc 2005; 293: 1082–8
   PubMed Web of Science ®Google Scholar
• Ellinson M., Thomas J., Patterson A. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet 2004; 17: 371–83, quiz 385–7
   PubMed Web of Science ®Google Scholar
• McMahon J. A., Green T. J., Skeaff C. M., Knight R. G., Mann J. I., Williams S. M. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006; 354: 2764–72
   PubMed Web of Science ®Google Scholar
• Malouf M., Grimley E. J., Areosa S. A. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev 2003; CD004514
   Google Scholar
• Hallmans G., Agren A., Johansson G., Johansson A., Stegmayr B., Jansson J. H., et al. Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort – evaluation of risk factors and their interactions. Scand J Public Health 2003; Suppl 61: 18–24
   Web of Science ®Google Scholar
• Stegmayr B., Lundberg V., Asplund K. The events registration and survey procedures in the Northern Sweden MONICA Project. Scand J Public Health 2003; Suppl 61: 9–17
   Google Scholar
• Smith D. E., Kok R. M., Teerlink T., Jakobs C., Smulders Y. M. Quantitative determination of erythrocyte folate vitamer distribution by liquid chromatography–tandem mass spectrometry. Clin Chem Lab Med 2006; 44: 450–9
   PubMedGoogle Scholar
• Herbert V., Larrabee A. R., Buchanan J. M. Studies on the identification of a folate compound of human serum. J Clin Invest 1962; 41: 1134–8
   PubMed Web of Science ®Google Scholar
• Refsum H., Nurk E., Smith A. D., Ueland P. M., Gjesdal C. G., Bjelland I., et al. The Hordaland Homocysteine Study: a community‐based study of homocysteine, its determinants, and associations with disease. J Nutr 2006; 136: 1731S–40S
   PubMed Web of Science ®Google Scholar
• Nurk E., Tell G. S., Vollset S. E., Nygard O., Refsum H., Nilsen R. M., et al. Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study. Am J Clin Nutr 2004; 79: 812–19
   PubMed Web of Science ®Google Scholar
• Jacques P. F., Bostom A. G., Wilson P. W., Rich S., Rosenberg I. H., Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001; 73: 613–21
   PubMed Web of Science ®Google Scholar
• Vollset S. E., Refsum H., Nygard O., Ueland P. M. Lifestyle factors associated with hyperhomocysteinemia. Homocysteine in Health and Disease, R Carmel, D. W Jacobsen. Cambridge University Press, Cambridge 2001
   Google Scholar
• Clarke R., Armitage J. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine‐lowering vitamin supplements. Semin Thromb Hemost 2000; 26: 341–8
   PubMed Web of Science ®Google Scholar
• Dose‐dependent effects of folic acid on blood concentrations of homocysteine: a meta‐analysis of the randomized trials. Am J Clin Nutr 2005; 82: 806–12
   PubMed Web of Science ®Google Scholar
• Cho E., Zeisel S. H., Jacques P., Selhub J., Dougherty L., Colditz G. A., et al. Dietary choline and betaine assessed by food‐frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am J Clin Nutr 2006; 83: 905–11
   PubMed Web of Science ®Google Scholar
• Gregory J. F. The bioavailability of folate. Folate in health and disease, L. B Bailey. Marcel Dekker, New York 1995
   Google Scholar
• Rosenblatt D. S., Erbe R. W. Methylenetetrahydrofolate reductase in cultured human cells. II. Genetic and biochemical studies of methylenetetrahydrofolate reductase deficiency. Pediatr Res 1977; 11: 1141–3
   PubMedGoogle Scholar
• Frosst P., Blom H. J., Milos R., Goyette P., Sheppard C. A., Matthews R. G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–13
   PubMed Web of Science ®Google Scholar
• Weisberg I. S., Jacques P. F., Selhub J., Bostom A. G., Chen Z., Curtis Ellison R., et al. The 1298A––>C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001; 156: 409–15
   PubMed Web of Science ®Google Scholar
• Casas J. P., Bautista L. E., Smeeth L., Sharma P., Hingorani A. D. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 2005; 365: 224–32
   PubMed Web of Science ®Google Scholar
• Lewis S. J., Ebrahim S., Davey Smith G. Meta‐analysis of MTHFR 677C–>T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?. Br Med J 2005; 331: 1053
   PubMed Web of Science ®Google Scholar
• Guenther B. D., Sheppard C. A., Tran P., Rozen R., Matthews R. G., Ludwig M. L. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol 1999; 6: 359–65
   PubMedGoogle Scholar
• Yamada K., Chen Z., Rozen R., Matthews R. G. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 2001; 98: 14853–8
   PubMed Web of Science ®Google Scholar
• McNulty H., Dowey le R. C., Strain J. J., Dunne A., Ward M., Molloy A. M., et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C–>T polymorphism. Circulation 2006; 113: 74–80
   PubMed Web of Science ®Google Scholar
• Moat S. J., Ashfield‐Watt P. A., Powers H. J., Newcombe R. G., McDowell I. F. Effect of riboflavin status on the homocysteine‐lowering effect of folate in relation to the MTHFR (C677T) genotype. Clin Chem 2003; 49: 295–302
   PubMed Web of Science ®Google Scholar
• Wilcken B., Bamforth F., Li Z., Zhu H., Ritvanen A., Renlund M., et al. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 2003; 40: 619–25
   PubMed Web of Science ®Google Scholar
• Gueant‐Rodriguez R. M., Gueant J. L., Debard R., Thirion S., Hong L. X., Bronowicki J. P., et al. Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am J Clin Nutr 2006; 83: 701–7
   PubMed Web of Science ®Google Scholar
• Munoz‐Moran E., Dieguez‐Lucena J. L., Fernandez‐Arcas N., Peran‐Mesa S., Reyes‐Engel A. Genetic selection and folate intake during pregnancy. Lancet 1998; 352: 1120–1
   PubMedGoogle Scholar
• Quere I., Mercier E., Bellet H., Janbon C., Mares P., Gris J. C. Vitamin supplementation and pregnancy outcome in women with recurrent early pregnancy loss and hyperhomocysteinemia. Fertil Steril 2001; 75: 823–5
   PubMedGoogle Scholar
• Lucock M., Yates Z. Folic acid – vitamin and panacea or genetic time bomb?. Nat Rev Genet 2005; 6: 235–40
   PubMed Web of Science ®Google Scholar
• Weisberg I., Tran P., Christensen B., Sibani S., Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64: 169–72
   PubMed Web of Science ®Google Scholar
• Ogino S., Wilson R. B. Genotype and haplotype distributions of MTHFR677C>T and 1298A>C single nucleotide polymorphisms: a meta‐analysis. J Hum Genet 2003; 48: 1–7
   PubMed Web of Science ®Google Scholar
• Duthie S. J., Narayanan S., Brand G. M., Pirie L., Grant G. Impact of folate deficiency on DNA stability. J Nutr 2002; 132: 2444S–9S
   PubMed Web of Science ®Google Scholar
• Wei Q., Shen H., Wang L. E., Duphorne C. M., Pillow P. C., Guo Z., et al. Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol Biomarkers Prev 2003; 12: 963–9
   PubMed Web of Science ®Google Scholar
• Choi S. W., Friso S., Dolnikowski G. G., Bagley P. J., Edmondson A. N., Smith D. E., et al. Biochemical and molecular aberrations in the rat colon due to folate depletion are age‐specific. J Nutr 2003; 133: 1206–12
   PubMedGoogle Scholar
• Narayanan S., McConnell J., Little J., Sharp L., Piyathilake C. J., Powers H., et al. Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo. Cancer Epidemiol Biomarkers Prev 2004; 13: 1436–43
   PubMed Web of Science ®Google Scholar
• Basten G. P., Duthie S. J., Pirie L., Vaughan N., Hill M. H., Powers H. J. Sensitivity of markers of DNA stability and DNA repair activity to folate supplementation in healthy volunteers. Br J Cancer 2006; 94: 1942–7
   PubMed Web of Science ®Google Scholar
• Chen R. Z., Pettersson U., Beard C., Jackson‐Grusby L., Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature 1998; 395: 89–93
   PubMed Web of Science ®Google Scholar
• Feinberg A. P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89–92
   PubMed Web of Science ®Google Scholar
• Jones P. A., Baylin S. B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415–28
   PubMed Web of Science ®Google Scholar
• Herman J. G., Baylin S. B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042–54
   PubMed Web of Science ®Google Scholar
• Esteller M., Corn P. G., Baylin S. B., Herman J. G. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225–9
   PubMed Web of Science ®Google Scholar
• Toyota M., Ahuja N., Ohe‐Toyota M., Herman J. G., Baylin S. B., Issa J. P. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681–6
   PubMed Web of Science ®Google Scholar
• Samowitz W. S., Albertsen H., Herrick J., Levin T. R., Sweeney C., Murtaugh M. A., et al. Evaluation of a large, population‐based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005; 129: 837–45
   PubMed Web of Science ®Google Scholar
• Weisenberger D. J., Siegmund K. D., Campan M., Young J., Long T. I., Faasse M. A., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38: 787–93
   PubMed Web of Science ®Google Scholar
• Ogino S., Cantor M., Kawasaki T., Brahmandam M., Kirkner G. J., Weisenberger D. J., et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 2006; 55: 1000–6
   PubMed Web of Science ®Google Scholar
• Henrique R., Jeronimo C. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Eur Urol 2004; 46: 660–9, discussion 669
   PubMed Web of Science ®Google Scholar
• Jeronimo C., Henrique R., Hoque M. O., Mambo E., Ribeiro F. R., Varzim G., et al. A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 2004; 10: 8472–8
   PubMed Web of Science ®Google Scholar
• Pufulete M., Al‐Ghnaniem R., Khushal A., Appleby P., Harris N., Gout S., et al. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut 2005; 54: 648–53
   PubMed Web of Science ®Google Scholar
• Waterland R. A., Jirtle R. L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23: 5293–300
   PubMed Web of Science ®Google Scholar
• Kim Y. I. Will mandatory folic acid fortification prevent or promote cancer?. Am J Clin Nutr 2004; 80: 1123–8
   PubMed Web of Science ®Google Scholar
• Kim Y. I. Role of folate in colon cancer development and progression. J Nutr 2003; 133: 3731S–39S
   PubMed Web of Science ®Google Scholar
• Charles D., Ness A. R., Campbell D., Davey Smith G., Hall M. H. Taking folate in pregnancy and risk of maternal breast cancer. Br Med J 2004; 329: 1375–6
   PubMed Web of Science ®Google Scholar
• Sanjoaquin M. A., Allen N., Couto E., Roddam A. W., Key T. J. Folate intake and colorectal cancer risk: a meta‐analytical approach. Int J Cancer 2005; 113: 825–8
   PubMed Web of Science ®Google Scholar
• Zhang S. M., Moore S. C., Lin J., Cook N. R., Manson J. E., Lee I. M., et al. Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol 2006; 163: 108–15
   PubMed Web of Science ®Google Scholar
• Larsson S. C., Giovannucci E., Wolk A. A prospective study of dietary folate intake and risk of colorectal cancer: modification by caffeine intake and cigarette smoking. Cancer Epidemiol Biomarkers Prev 2005; 14: 740–3
   PubMed Web of Science ®Google Scholar
• Wei E. K., Giovannucci E., Wu K., Rosner B., Fuchs C. S., Willett W. C., et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer 2004; 108: 433–42
   PubMed Web of Science ®Google Scholar
• Konings E. J., Goldbohm R. A., Brants H. A., Saris W. H., van den Brandt P. A. Intake of dietary folate vitamers and risk of colorectal carcinoma: results from The Netherlands Cohort Study. Cancer 2002; 95: 1421–33
   PubMed Web of Science ®Google Scholar
• Su L. J., Arab L. Nutritional status of folate and colon cancer risk: evidence from NHANES I epidemiologic follow‐up study. Ann Epidemiol 2001; 11: 65–72
   PubMed Web of Science ®Google Scholar
• Giovannucci E., Stampfer M. J., Colditz G. A., Hunter D. J., Fuchs C., Rosner B. A., et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998; 129: 517–24
   PubMed Web of Science ®Google Scholar
• Paspatis G. A., Karamanolis D. G. Folate supplementation and adenomatous colonic polyps. Dis Colon Rectum 1994; 37: 1340–1
   PubMedGoogle Scholar
• Khosraviani K., Weir H. P., Hamilton P., Moorehead J., Williamson K. Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut 2002; 51: 195–9
   PubMedGoogle Scholar
• Knock E., Deng L., Wu Q., Leclerc D., Wang X. L., Rozen R. Low dietary folate initiates intestinal tumors in mice, with altered expression of G2‐M checkpoint regulators polo‐like kinase 1 and cell division cycle 25c. Cancer Res 2006; 66: 10349–56
   PubMedGoogle Scholar
• Cole B. F., Baron J. A., Sandler R. S., Haile R. W., Ahnen D. J., Bresalier R. S., et al. A randomized trial of folic acid to prevent colorectal adenomas. Proc Am Assoc Cancer Res 2005; 46: 4399
   Google Scholar
• Ma J., Stampfer M. J., Giovannucci E., Artigas C., Hunter D. J., Fuchs C., et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57: 1098–102
   PubMed Web of Science ®Google Scholar
• Glynn S. A., Albanes D., Pietinen P., Brown C. C., Rautalahti M., Tangrea J. A., et al. Colorectal cancer and folate status: a nested case‐control study among male smokers. Cancer Epidemiol Biomarkers Prev 1996; 5: 487–94
   PubMed Web of Science ®Google Scholar
• Kato I., Dnistrian A. M., Schwartz M., Toniolo P., Koenig K., Shore R. E., et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case‐control study. Br J Cancer 1999; 79: 1917–22
   PubMed Web of Science ®Google Scholar
• Rossi E., Hung J., Beilby J. P., Knuiman M. W., Divitini M. L., Bartholomew H. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia. Ann Epidemiol 2006; 16: 206–12
   PubMed Web of Science ®Google Scholar
• Van Guelpen B., Hultdin J., Johansson I., Hallmans G., Stenling R., Riboli E., et al. Low folate levels may protect against colorectal cancer. Gut 2006; 55: 1461–6
   PubMed Web of Science ®Google Scholar
• Pelucchi C., Galeone C., Talamini R., Negri E., Parpinel M., Franceschi S., et al. Dietary folate and risk of prostate cancer in Italy. Cancer Epidemiol Biomarkers Prev 2005; 14: 944–8
   PubMed Web of Science ®Google Scholar
• Stevens V. L., Rodriguez C., Pavluck A. L., McCullough M. L., Thun M. J., Calle E. E. Folate nutrition and prostate cancer incidence in a large cohort of US men. Am J Epidemiol 2006; 163: 989–96
   PubMed Web of Science ®Google Scholar
• Weinstein S. J., Hartman T. J., Stolzenberg‐Solomon R., Pietinen P., Barrett M. J., Taylor P. R., et al. Null association between prostate cancer and serum folate, vitamin B(6), vitamin B(12), and homocysteine. Cancer Epidemiol Biomarkers Prev 2003; 12: 1271–2
   PubMed Web of Science ®Google Scholar
• Hultdin J., Van Guelpen B., Bergh A., Hallmans G., Stattin P. Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study. Int J Cancer 2005; 113: 819–24
   PubMed Web of Science ®Google Scholar
• Cicek M. S., Nock N. L., Li L., Conti D. V., Casey G., Witte J. S. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cancer Epidemiol Biomarkers Prev 2004; 13: 1331–6
   PubMedGoogle Scholar
• Heijmans B. T., Boer J. M., Suchiman H. E., Cornelisse C. J., Westendorp R. G., Kromhout D., et al. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res 2003; 63: 1249–53
   PubMed Web of Science ®Google Scholar
• Kimura F., Franke K. H., Steinhoff C., Golka K., Roemer H. C., Anastasiadis A. G., et al. Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma. Prostate 2000; 45: 225–31
   PubMed Web of Science ®Google Scholar
• Singal R., Ferdinand L., Das P. M., Reis I. M., Schlesselman J. J. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. Int J Oncol 2004; 25: 1465–71
   PubMed Web of Science ®Google Scholar
• Van Guelpen B. R., Wiren S. M., Bergh A. R., Hallmans G., Stattin P. E., Hultdin J. Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case‐control study. Eur J Cancer Prev 2006; 15: 46–50
   PubMed Web of Science ®Google Scholar
• Sharp L., Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 2004; 159: 423–43
   PubMed Web of Science ®Google Scholar
• Ulvik A., Vollset S. E., Hansen S., Gislefoss R., Jellum E., Ueland P. M. Colorectal cancer and the methylenetetrahydrofolate reductase 677C–>T and methionine synthase 2756A–>G polymorphisms: a study of 2,168 case‐control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004; 13: 2175–80
   PubMed Web of Science ®Google Scholar
• Eaton A. M., Sandler R., Carethers J. M., Millikan R. C., Galanko J., Keku T. O. 5,10‐methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2023–9
   PubMedGoogle Scholar
• Le Marchand L., Wilkens L. R., Kolonel L. N., Henderson B. E. The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2005; 14: 1198–203
   PubMed Web of Science ®Google Scholar
• Chen J., Giovannucci E., Kelsey K., Rimm E. B., Stampfer M. J., Colditz G. A., et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996; 56: 4862–4
   PubMed Web of Science ®Google Scholar
• Curtin K., Bigler J., Slattery M. L., Caan B., Potter J. D., Ulrich C. M. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 285–92
   PubMed Web of Science ®Google Scholar
• Keku T., Millikan R., Worley K., Winkel S., Eaton A., Biscocho L., et al. 5,10‐Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 2002; 11: 1611–21
   PubMed Web of Science ®Google Scholar
• Schnyder G., Roffi M., Flammer Y., Pin R., Hess O. M. Effect of homocysteine‐lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. J Am Med Assoc 2002; 288: 973–9
   PubMed Web of Science ®Google Scholar
• Schnyder G., Roffi M., Pin R., Flammer Y., Lange H., Eberli F. R., et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001; 345: 1593–600
   PubMed Web of Science ®Google Scholar
• Lange H., Suryapranata H., De Luca G., Borner C., Dille J., Kallmayer K., et al. Folate therapy and in‐stent restenosis after coronary stenting. N Engl J Med 2004; 350: 2673–81
   PubMed Web of Science ®Google Scholar
• Yang Q., Botto L. D., Erickson J. D., Berry R. J., Sambell C., Johansen H., et al. Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 2006; 113: 1335–43
   PubMed Web of Science ®Google Scholar
• Moat S. J., Lang D., McDowell I. F., Clarke Z. L., Madhavan A. K., Lewis M. J., et al. Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem 2004; 15: 64–79
   PubMed Web of Science ®Google Scholar
• Verhaar M. C., Wever R. M., Kastelein J. J., van Dam T., Koomans H. A., Rabelink T. J. 5‐methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 1998; 97: 237–41
   PubMed Web of Science ®Google Scholar
• Usui M., Matsuoka H., Miyazaki H., Ueda S., Okuda S., Imaizumi T. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. Clin Sci (Lond) 1999; 96: 235–9
   PubMedGoogle Scholar
• Doshi S. N., McDowell I. F., Moat S. J., Lang D., Newcombe R. G., Kredan M. B., et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?. Arterioscler Thromb Vasc Biol 2001; 21: 1196–202
   PubMed Web of Science ®Google Scholar
• Doshi S. N., McDowell I. F., Moat S. J., Payne N., Durrant H. J., Lewis M. J., et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002; 105: 22–6
   PubMed Web of Science ®Google Scholar
• Mangoni A. A., Sherwood R. A., Swift C. G., Jackson S. H. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J Intern Med 2002; 252: 497–503
   PubMed Web of Science ®Google Scholar
• Mangoni A. A., Arya R., Ford E., Asonganyi B., Sherwood R. A., Ouldred E., et al. Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial. Thromb Res 2003; 110: 13–17
   PubMed Web of Science ®Google Scholar
• Spijkerman A. M., Smulders Y. M., Kostense P. J., Henry R. M., Becker A., Teerlink T., et al. S‐Adenosylmethionine and 5‐methyltetrahydrofolate are associated with endothelial function after controlling for confounding by homocysteine. The Hoorn Study. Arterioscler Thromb Vasc Biol 2005
   PubMedGoogle Scholar
• Chasan‐Taber L., Selhub J., Rosenberg I. H., Malinow M. R., Terry P., Tishler P. V., et al. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr 1996; 15: 136–43
   PubMed Web of Science ®Google Scholar
• de Bree A., Verschuren W. M., Blom H. J., Nadeau M., Trijbels F. J., Kromhout D. Coronary heart disease mortality, plasma homocysteine, and B‐vitamins: a prospective study. Atherosclerosis 2003; 166: 369–77
   PubMedGoogle Scholar
• Voutilainen S., Virtanen J. K., Rissanen T. H., Alfthan G., Laukkanen J., Nyyssonen K., et al. Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 2004; 80: 317–23
   PubMed Web of Science ®Google Scholar
• Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case‐control study. Lancet 2004; 364: 937–52
   PubMed Web of Science ®Google Scholar
• McCarty M. F. Coping with endothelial superoxide: potential complementarity of arginine and high‐dose folate. Med Hypotheses 2004; 63: 709–18
   PubMedGoogle Scholar
• Forstermann U., Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006; 113: 1708–14
   PubMed Web of Science ®Google Scholar
• Griffith T. M., Chaytor A. T., Bakker L. M., Edwards D. H. 5‐Methyltetrahydrofolate and tetrahydrobiopterin can modulate electrotonically mediated endothelium‐dependent vascular relaxation. Proc Natl Acad Sci USA 2005; 102: 7008–13
   PubMed Web of Science ®Google Scholar
• Morrison H. I., Schaubel D., Desmeules M., Wigle D. T. Serum folate and risk of fatal coronary heart disease. J Am Med Assoc 1996; 275: 1893–6
   PubMed Web of Science ®Google Scholar
• Zeitlin A., Frishman W. H., Chang C. J. The association of vitamin b 12 and folate blood levels with mortality and cardiovascular morbidity incidence in the old old: the Bronx aging study. Am J Ther 1997; 4: 275–81
   PubMedGoogle Scholar
• Folsom A. R., Nieto F. J., McGovern P. G., Tsai M. Y., Malinow M. R., Eckfeldt J. H., et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998; 98: 204–10
   PubMedGoogle Scholar
• Ford E. S., Byers T. E., Giles W. H. Serum folate and chronic disease risk: findings from a cohort of United States adults. Int J Epidemiol 1998; 27: 592–8
   PubMedGoogle Scholar
• Giles W. H., Kittner S. J., Croft J. B., Anda R. F., Casper M. L., Ford E. S. Serum folate and risk for coronary heart disease: results from a cohort of US adults. Ann Epidemiol 1998; 8: 490–6
   PubMedGoogle Scholar
• Rimm E. B., Willett W. C., Hu F. B., Sampson L., Colditz G. A., Manson J. E., et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. J Am Med Assoc 1998; 279: 359–64
   PubMed Web of Science ®Google Scholar
• Loria C. M., Ingram D. D., Feldman J. J., Wright J. D., Madans J. H. Serum folate and cardiovascular disease mortality among US men and women. Arch Intern Med 2000; 160: 3258–62
   PubMedGoogle Scholar
• Voutilainen S., Rissanen T. H., Virtanen J., Lakka T. A., Salonen J. T. Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 2001; 103: 2674–80
   PubMed Web of Science ®Google Scholar
• Hung J., Beilby J. P., Knuiman M. W., Divitini M. Folate and vitamin B‐12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia. Br Med J 2003; 326: 131
   PubMedGoogle Scholar
• Drogan D., Klipstein‐Grobusch K., Dierkes J., Weikert C., Boeing H. Dietary intake of folate equivalents and risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition (EPIC) – Potsdam study. Public Health Nutr 2006; 9: 465–71
   PubMedGoogle Scholar
• Giles W. H., Kittner S. J., Anda R. F., Croft J. B., Casper M. L. Serum folate and risk for ischemic stroke. First National Health and Nutrition Examination Survey epidemiologic follow‐up study. Stroke 1995; 26: 1166–70
   PubMed Web of Science ®Google Scholar
• Bazzano L. A., He J., Ogden L. G., Loria C., Vupputuri S., Myers L., et al. Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow‐up Study. National Health and Nutrition Examination Survey. Stroke 2002; 33: 1183–8
   PubMed Web of Science ®Google Scholar
• Maxwell C. J., Hogan D. B., Ebly E. M. Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons. Dement Geriatr Cogn Disord 2002; 13: 225–34
   PubMed Web of Science ®Google Scholar
• He K., Merchant A., Rimm E. B., Rosner B. A., Stampfer M. J., Willett W. C., et al. Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 2004; 35: 169–74
   PubMed Web of Science ®Google Scholar
• Al‐Delaimy W. K., Rexrode K. M., Hu F. B., Albert C. M., Stampfer M. J., Willett W. C., et al. Folate intake and risk of stroke among women. Stroke 2004; 35: 1259–63
   PubMedGoogle Scholar
• Gartside P. S., Glueck C. J. The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: the prospective NHANES I follow‐up study. J Am Coll Nutr 1995; 14: 71–9
   PubMed Web of Science ®Google Scholar
• Ross R. K., Yuan J. M., Henderson B. E., Park J., Gao Y. T., Yu M. C. Prospective evaluation of dietary and other predictors of fatal stroke in Shanghai, China. Circulation 1997; 96: 50–5
   PubMed Web of Science ®Google Scholar
• Van Guelpen B., Hultdin J., Johansson I., Stegmayr B., Hallmans G., Nilsson T. K., et al. Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: a prospective, nested case‐referent study of plasma concentrations and dietary intake. Stroke 2005; 36: 1426–31
   PubMed Web of Science ®Google Scholar
• Lonn E., Yusuf S., Arnold M. J., Sheridan P., Pogue J., Micks M., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354: 1567–77
   PubMed Web of Science ®Google Scholar
• Bonaa K. H., Njolstad I., Ueland P. M., Schirmer H., Tverdal A., Steigen T., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354: 1578–88
   PubMed Web of Science ®Google Scholar
• Liem A., Reynierse‐Buitenwerf G. H., Zwinderman A. H., Jukema J. W., van Veldhuisen D. J. Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol 2003; 41: 2105–13
   PubMedGoogle Scholar
• Liem A., Reynierse‐Buitenwerf G. H., Zwinderman A. H., Jukema J. W., van Veldhuisen D. J. Secondary prevention with folic acid: results of the Goes extension study. Heart 2005; 91: 1213–4
   PubMed Web of Science ®Google Scholar
• Toole J. F., Malinow M. R., Chambless L. E., Spence J. D., Pettigrew L. C., Howard V. J., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. J Am Med Assoc 2004; 291: 565–75
   PubMed Web of Science ®Google Scholar
• Homocysteine‐lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 2006; 151: 282–7
   PubMed Web of Science ®Google Scholar
• Lentz S. R. Mechanisms of homocysteine‐induced atherothrombosis. J Thromb Haemost 2005; 3: 1646–54
   PubMed Web of Science ®Google Scholar
• Cronin S., Furie K. L., Kelly P. J. Dose‐related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta‐analysis. Stroke 2005; 36: 1581–7
   PubMed Web of Science ®Google Scholar
• Kelly P. J., Rosand J., Kistler J. P., Shih V. E., Silveira S., Plomaritoglou A., Furie K. L. Homocysteine, MTHFR 677C–>T polymorphism, and risk of ischemic stroke: results of a meta‐analysis. Neurology 2002; 59: 529–36
   PubMed Web of Science ®Google Scholar
• Wald D. S., Law M., Morris J. K. Homocysteine and cardiovascular disease: evidence on causality from a meta‐analysis. Br Med J 2002; 325: 1202
   PubMed Web of Science ®Google Scholar
• Kim R. J., Becker R. C. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta‐analysis of published studies. Am Heart J 2003; 146: 948–57
   PubMed Web of Science ®Google Scholar
• Klerk M., Verhoef P., Clarke R., Blom H. J., Kok F. J., Schouten E. G. MTHFR 677C–>T polymorphism and risk of coronary heart disease: a meta‐analysis. J Am Med Assoc 2002; 288: 2023–31
   PubMed Web of Science ®Google Scholar